Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes-Reference-Cited by-同舟云学术

Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes

Published:2016-07-18 Issue:5 Volume:85 Page:772-780
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Dhindsa Sandeep¹²,Ghanim Husam¹,Batra Manav¹,Kuhadiya Nitesh D.¹,Abuaysheh Sanaa¹,Green Kelly¹,Makdissi Antoine¹,Chaudhuri Ajay¹,Dandona Paresh¹

Affiliation:

1. Division of Endocrinology, Diabetes and Metabolism; State University of New York at Buffalo; Buffalo NY USA

2. Division of Endocrinology, Diabetes and Metabolism; Texas Tech University Health Sciences Center; Odessa TX USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

GlaxoSmithKline

Center for Disease Control

Bristol-Myers Squibb

Novartis Pharmaceuticals

Abbott Laboratories

Takeda Pharmaceuticals

Sankyo Pharmaceuticals North America

Oishei Foundation

Citrus Industry of Florida

Solvay Pharmaceuticals

William G. McGowan Charitable Fund

Millard Fillmore Foundation

Eli Lilly

Novartis

Merck

Novo Nordisk

Abbvie

Sanofi-Aventis

Allergan

Conjuchem

Dannipon Pharmaceuticals

Proctor and Gamble Pharma

Mitsubishi

Quigley Pharma Inc.

Transition Therapeutics

ToleRx

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference36 articles.

1. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes;Dhindsa;Journal of Clinical Endocrinology and Metabolism,2004

2. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity;Dandona;Journal of Clinical Endocrinology and Metabolism,2011

3. Low testosterone levels are common and associated with insulin resistance in men with diabetes;Grossmann;Journal of Clinical Endocrinology and Metabolism,2008

4. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity;Kapoor;Diabetes Care,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testosterone and Erythrocyte Lifespan;The Journal of Clinical Endocrinology & Metabolism;2024-06-24

2. Management of male obesity-related secondary hypogonadism: A clinical update;World Journal of Experimental Medicine;2024-06-20

3. Increased risk of erythrocytosis in men with type 2 diabetes treated with combined sodium-glucose cotransporter-2 inhibitor and testosterone replacement therapy;Journal of Endocrinological Investigation;2024-03-27

4. Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study;Biomedicines;2023-11-29

5. Impact of testosterone therapy on bone turnover markers in obese males with type 2 diabetes and functional hypogonadism;The Aging Male;2022-11-10